References
- Gasbariini A, Franceschi F, Tartaglione R, Landolfi R, Pola P, Gasbamni G. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet 1998;352:878.
- Emilia G, Longo G, Luppi M, Gandini G, Morselli M, Ferrara L, et al. Helicobacter pylori eradication can induce platelet recovery in idiopathic thrombocytopenic purpura. Blood 2001; 97:812–4.
- Jarque I, Andreu R, Llopis I, De La Rupia J, Gomis F, Senent L, et al. Absence of platelet response after eradication of Helicobacter pylori infection in patients with chronic idiopathic thrombocytopenic purpura. Br J Hematol 2001;115:1002–3.
- Michel M, Khellaf M, Desforges L, Lee K, Schaeffer A, Godeau B, et al. Autoimmune thrombocytopenic purpura and Helicobacter pylori infection. Arch Intern Med 2002;162:1033–6.
- Tohda S, Ohkusa T. Resolution of refractory idiopathic thrombocytopenic purpura after eradication of Helicobacter pylori. Am J Hematol 2000;65:329–30.
- Soldinger E, Pilia MC, Piubello W, Nadali G. Multi-resistant idiopathic thrombocytopenia successfully treated by eradication of Helicobacter pylori. Dig Liver Dis 2001;33:732.
- Grimaz S, Damiani D, Brosolo P, Skert C, Geromin A, De Pretis G. Resolution of thrombocytopenia after treatment for Helicobacter pylori: a case report. Haematologica 1999;84: 283–4.
- Akiyama H, Yasusuke O. Effect of omeprazole in chronic idiopathic thrombocytopenic purpura. Am J Hematol 1998;57:91–2.
- McCrae KR, Bussel JB, Mannucci PM, Remuzzi G, Cines DB. Platelets: an update on diagnosis and management of thrombocytopenic disorders. Hematology 2001:282–305.
- Franceschi F, Genta RM, Gasbarrini A. Anti-CagA antibodies cross-react with human platelet antigens. Gut 2000;47 Suppl:A87.
References
- Rossle M, Haag K, Ochs A, Sellinger M, Noldge G, Pernau JM, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 1994;330:165–71.
- Ochs A, Rossle M, Haag K, Hauenstein KH, Deibert P, Siegerstetter V, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 1995;332:1192–7.
- LaBerge JM, Somberg KA, Lake JR, Gordon RL, Kerlan RK, Ascher NL, et al. Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology 1995;108:1143–51.
- Haskal ZJ, Brennecke LH. Transjugular intrahepatic portosystemic shunts formed with polyethylene terephthalate-covered stents: experimental evaluation in pigs. Radiology 1999; 213:853–9.
- Cejna M, Thurnher S, Pidlich J, Kaserer K, Schoder M, Lammer J. Primary implantation of polyester-covered stent-graft for transjugular intrahepatic portosystemic stent shunts (TIPSS): a pilot study. Cardiovasc Intervent Radiol 1999;22:305–10.
- Cejna M, Peck-Radosavljevic M, Thurnher SA, Hittmair K, Schoder M, Lammer J. Creation of transjugular intrahepatic portosystemic shunts with stent-grafts: initial experiences with a polytetrafluoroethylene-covered nitinol endoprothesis. Radiology 2001;221:437–46.
- Otal P, Smayra T, Bureau C, Peron JM, Chabbert V, Chemla P, et al. Preliminary results of a new expanded-polytetrafluoro- ethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt procedures. Am J Roentgenol 2002;178:141–7.
- Burroughs AK, Vangeli M. Transjugular intrahepatic portosystemic shunt versus endoscopic therapy: randomised trials for secondary prophylaxis of variceal bleeding. An updated metaanalysis. Scand J Gastroenterol 2002;37:249–252.
- Amodio P, Wenin H, Del Piccolo F, Mapelli D, Montagnose S, Pellegrini A, et al. Variability of trail making tests, symbol digit test and line trait test in normal people. A normative study taking into account age-dependent decline and sociobiological variables. Aging Clin Exp Res 2002;14:117–31.
- Riggio O, Merli M, Pedretti G, Servi R, Meddi P, Lionetti R, et al. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Incidence and risk factors. Dig Dis Sci 1996;41:578–84.
- Hauenstein KH, Haag K, Ochs A, Langer M, Rossle M. The reducing stent treatment for transjugular intrahepatic portosystemic shunt induced refractory hepatic encephalopathy and liver failure. Radiology 1995;194:175–9.